Miromatrix Medical Q3 EPS $(0.24) Misses $(0.21) Estimate, Sales $11.18K Down From $12.39K YoY
Portfolio Pulse from Benzinga Newsdesk
Miromatrix Medical (NASDAQ:MIRO) reported a Q3 EPS loss of $(0.24), missing the $(0.21) estimate, and sales of $11.18K, down from $12.39K YoY, indicating a decrease in performance compared to the same period last year.
November 14, 2023 | 9:37 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Miromatrix Medical reported a larger than expected quarterly loss and a decrease in sales compared to last year, indicating potential concerns over the company's performance.
The reported earnings miss and year-over-year decline in sales are likely to negatively impact investor sentiment in the short term, potentially leading to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100